Clinical Trial Update: Isolated Limb Perfusion With Melphalan in Treating Patients With Stage IIIB-IV Melanoma or Sarcoma [NA]

View source ↗

Summary

A clinical trial evaluating isolated limb perfusion with melphalan for stage IIIB-IV melanoma or soft tissue sarcoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Soft Tissue Sarcoma

Drugs mentioned

• Melphalan (Alkeran) (melphalan)

Snippet

Sponsor: Albert Einstein College of Medicine | Conditions: Basal Cell Carcinoma of the Skin, Eccrine Carcinoma of the Skin | NA | Status: WITHDRAWN